SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Board Changes

4 Jan 2024 16:34

RNS Number : 7082Y
James Halstead PLC
04 January 2024
 

 

4th January 2024

James Halstead PLC

(the "Company")

 

Board Changes

 

James Halstead plc (AIM: JHD), a leading manufacturer and international distributor of commercial floor coverings, is pleased to announce the following appointments to the Board, with effect from 8th January 2024:

 

i. David Drillingcourt will join the Board in an executive director role as Corporate Development Director. David, a Chartered Accountant, joined the Company in 1996 and during his time with the Company has held many senior group roles, including the Finance Director of Polyflor Limited and Group Company Secretary. Recently, in the role of Corporate Development, he has been responsible for developing and supporting the growth of the business across the globe.

 

ii. Deborah Harrison will join the Board as an independent non-executive director. Deborah is a Chartered Accountant and has over thirty years of experience working for a top tier accounting firm, providing auditing and accounting services to a wide range of organisations and sectors. Deborah will also sit as a member of the audit committee and remuneration committee. 

 

The Company also announces that, having served on the Board for over ten years, non-executive director Stephen Hall will be stepping down with effect from 1st March 2024. A further announcement regarding the appointment of the new Senior Independent Director will be made at the time of his departure.

 

Commenting, Mr Mark Halstead, Chief Executive of James Halstead plc, said:

 

"We are extremely pleased to welcome both Deborah and David to the James Halstead board.

Deborah will bring to the board her significant experience of dealing with international groups of companies, including acquisitions and disposals, and her knowledge of corporate reporting requirements will further enhance the Board's financial expertise.

 

David's extensive knowledge of the Company and his flooring industry experience will play an important role in supporting the board in its strategic aim of growing the global footprint of the business.

 

I also would like to thank Stephen for his contribution to James Halstead plc in his role as non-executive director through an important period which has seen the business grow and overcome significant challenges. We wish him the very best for the future."

Additional Information

In accordance with the AIM Rules, the following additional information is required to be disclosed. Other than this information, there is no further information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules.

 

Full name and age

David William Drillingcourt, aged 55.

 

Current beneficial shareholding in the Company

7,700 ordinary shares beneficially owned with options over a further 240,000 ordinary shares.

 

Current directorships

Polyflor (M) SDN BHD

 

Former directorships (previous five years)

None.

 

Full name and age

Deborah Ann Harrison, aged 63.

 

Current beneficial shareholding in the Company

None.

 

Current directorships

None.

 

Former directorships (previous five years)

None.

 

 

 

For further information please contact:

 

James Halstead plc

David Fletcher, Company Secretary

Telephone 0161 767 2500

 

 

Hudson Sandler

Nick Lyon

Nick Moore

Telephone: 020 7796 4133

 

Panmure Gordon (NOMAD & Joint Broker)

Dominic Morley

Telephone: 020 7886 2500

 

WH Ireland (Joint Broker)

Ben Thorne

 

Telephone: 020 7220 1666

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUSONRSUUARAR
Date   Source Headline
6th Dec 20198:30 amRNSAGM Statement
18th Oct 20199:51 amRNSNotice of Results
1st Oct 20197:00 amRNSPreliminary Results
18th Sep 20197:00 amRNSNotice of Preliminary Results
23rd Aug 20194:37 pmRNSPrice Monitoring Extension
30th Jul 20197:00 amRNSPre-Close Trading Statement
3rd Jul 20194:41 pmRNSNew Corporate Website
3rd Jun 201910:31 amRNSTotal Voting Rights
15th May 20198:08 amRNSDirector/PDMR Shareholding
10th May 20192:36 pmRNSDirector/PDMR Shareholding
3rd May 20192:07 pmRNSTotal Voting Rights
2nd Apr 20199:57 amRNSBlock listing Interim Review
1st Apr 20196:19 pmRNSTotal Voting Rights
29th Mar 20197:00 amRNSInterim Results
28th Mar 20191:24 pmRNSNotice of Interim Results - Update
25th Mar 20199:35 amRNSNotice of Interim Results
30th Jan 20197:00 amRNSPre Close Trading Statement
28th Jan 20191:16 pmRNSDirector/PDMR Shareholding
7th Dec 20184:13 pmRNSResult of AGM
7th Dec 20187:00 amRNSAGM Statement
19th Oct 20184:02 pmRNSAnnual Financial Report and Notice of AGM
19th Oct 20187:00 amRNSDirector/PDMR Shareholding
18th Oct 20187:00 amRNSAdditional Listing
18th Oct 20187:00 amRNSTotal Voting Rights
16th Oct 20186:13 pmRNSBlock listing Interim Review
27th Sep 20184:48 pmRNSDirector/PDMR Shareholding
26th Sep 20187:00 amRNSPreliminary Results
17th Sep 20187:00 amRNSNotice of Preliminary Results
25th Jul 20187:00 amRNSPre-Close Trading Statement
22nd May 20184:58 pmRNSRule 2.8 Announcement
22nd May 20189:39 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
21st May 20189:46 amRNSForm 8.3 - James Halstead
18th May 20182:52 pmRNSForm 8.3 - James Halstead
18th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
17th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
17th May 20187:57 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
16th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
15th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
14th May 201811:57 amRNSForm 8.5 (EPT/NON-RI)
11th May 20183:26 pmRNSDirector/PDMR Shareholding
11th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
11th May 201810:20 amRNSForm 8.3 - James Halstead
11th May 20189:07 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
10th May 20181:36 pmRNSDirector/PDMR Shareholding
10th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
10th May 20189:12 amRNSForm 8.3 - James Halstead
9th May 20183:29 pmBUSForm 8.3 - James Halstead PLC
9th May 201811:57 amRNSForm 8.5 (EPT/NON-RI)
9th May 201811:57 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
8th May 20181:22 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.